MYRIAD GENETICS, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $166.3M | $161.3M | $5.0M | $31.6M |
| FY2017 | $106.2M | $100.1M | $6.1M | $29.9M |
| FY2018 | $115.9M | $107.5M | $8.4M | $27.1M |
| FY2019 | $83.7M | $75.1M | $8.6M | $33.5M |
| FY2020 | $60.7M | $50.5M | $10.2M | $25.2M |
| FY2021 | $18.6M | $600.0K | $18.0M | $36.3M |
| FY2022 | $-106.3M | $-151.6M | $45.3M | $38.1M |
| FY2023 | $-110.9M | $-110.9M | — | $40.7M |
| FY2024 | $-8.7M | $-8.7M | — | $49.8M |
| FY2025 | $1.8M | $1.8M | — | $35.2M |